Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating deployment of site updates; the study page content remains unchanged.SummaryDifference0.0%

- Check19 days agoChange DetectedUpdated the page revision tag from v3.6.0 to v3.6.2, indicating a new build of the page. This change affects only metadata and does not alter visible content or interactions.SummaryDifference0.0%

- Check33 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' signaling that enrollment for this study has ended. The update also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and applies minor formatting changes to the Intervention/Treatment label, along with a new site revision tag v3.6.0.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page's revision tag updated from v3.5.4 to v3.5.5 in the site metadata. This indicates a platform update rather than any modification to the study content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study record revision was updated from v3.5.3 to v3.5.4, reflecting a new document revision in the study history. This change indicates an update to the study documentation on ClinicalTrials.gov.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page shows a revision update from v3.5.2 to v3.5.3, indicating a minor metadata/build change. This does not modify the study details or content presented on the page.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.